NKT5097

· NiKang Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKT5097, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]